Myriad Genetics (NASDAQ: MYGN) CFO uses 8,761 shares to cover RSU taxes

Rhea-AI Filing Summary

MYRIAD GENETICS INC executive Benjamin Richard Wheeler, Chief Financial Officer, reported a Form 4 transaction involving company common stock. On August 16, 2026, 8,761 shares were withheld by the issuer to cover tax withholding obligations arising from the vesting of previously granted restricted stock units. After this tax-withholding disposition, Wheeler’s directly held common stock position is 289,748 shares.

Insider Trade Summary

Net Seller: 8,761 shares

Net Sell 1 txn

Insider Wheeler Benjamin Richard

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	8,761	$3.03	$27K

Holdings After Transaction: Common Stock — 289,748 shares (Direct)

Footnotes (1)

1. F1. Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on August 14, 2026.

Key Figures

Shares withheld for taxes: 8,761 shares Per-share valuation for withholding: $3.03 per share Shares owned after transaction: 289,748 shares +1 more

4 metrics

Shares withheld for taxes 8,761 shares Common stock withheld to satisfy tax withholding obligations from RSU vesting on August 16, 2026

Per-share valuation for withholding $3.03 per share Value used to determine number of shares withheld, based on August 14, 2026 closing price

Shares owned after transaction 289,748 shares Directly owned MYGN common stock by Benjamin Richard Wheeler following the tax-withholding transaction

Exercise price or tax liability shares 8,761 shares Total shares reported under code F for payment of tax liability by withholding securities

Key Terms

restricted stock units, tax withholding obligations, withheld by the Issuer

3 terms

restricted stock units financial

"in connection with the vesting of restricted stock units previously granted"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"withheld by the Issuer to satisfy tax withholding obligations in connection"

withheld by the Issuer financial

"Represents shares of Common Stock withheld by the Issuer to satisfy"

FAQ

What insider transaction did MYGN CFO Benjamin Richard Wheeler report on this Form 4?

Wheeler reported a withholding of 8,761 MYGN common shares on August 16, 2026, used to satisfy tax obligations from vesting restricted stock units. This was recorded as a code F transaction, not an open-market purchase or sale.

How many MYGN shares were withheld for taxes in Benjamin Wheeler’s latest Form 4?

The filing shows 8,761 MYGN common shares were withheld to cover tax withholding obligations related to the vesting of restricted stock units. The number of shares was based on the closing price on August 14, 2026.

What is Benjamin Wheeler’s MYGN shareholding after the reported Form 4 transaction?

After the tax-withholding disposition, Wheeler directly holds 289,748 shares of MYRIAD GENETICS INC common stock. This figure reflects his post-transaction balance following the issuer’s withholding of shares for RSU-related tax obligations.

Was the MYGN Form 4 transaction an open-market buy or sell by Benjamin Wheeler?

No, the Form 4 reports a code F transaction, meaning shares were withheld to pay tax liabilities from RSU vesting. It does not represent an open-market purchase or sale by Wheeler.

At what price were the MYGN shares valued for Benjamin Wheeler’s tax withholding transaction?

The 8,761 withheld shares were valued at $3.03 per share, with the number of shares determined using the closing price of MYGN common stock on August 14, 2026, according to the footnote disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/17/2026 - 04:26 PM Accepted by SEC EDGAR 08/17/2026 - 04:26 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wheeler Benjamin Richard

(Last) (First) (Middle)

322 NORTH 2200 WEST

(Street)

SALT LAKE CITY UTAH 84116

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MYRIAD GENETICS INC [ MYGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/16/2026		F		8,761(1)	D	$3.03	289,748	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on August 14, 2026.

Remarks:

	By: Justin Hunter For: Benjamin R. Wheeler	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)